Form D · Biotechnology
Vibe Bioscience Corp
Calgary, A0 · CIK 0001768394
Offering snapshot reported Apr 9, 2019 · SEC filing
- Reported sold
- $338K Offering amount: $338K
- Investors reported
- 8 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 13, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 9, 2019 | Initial | $338,494 | No comparison | 8 | SEC filing |
| Apr 9, 2019 | Initial | $13,190,455 | No comparison | 6 | SEC filing |
| Feb 22, 2019 | Initial | $159,753 | No comparison | 9 | SEC filing |
Offering details
- Securities
- Equity, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-336853
February 13, 2019 Closing Cdn$1.3222 = US$1.00; March 12, 2019 Closing Cdn$1.3380 = US$1.00
Class A Common Shares
Source: Form D, filed Apr 9, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| John Ryan Mercier | Executive |
| Joe Starr | Director, Executive, Promoter |
| Mark Waldron | Director, Executive, Promoter |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
2505 17 Th Avenue S.W., #214
Calgary, A0, T3E 7V3
Calgary, A0, T3E 7V3